Follow
Ignatius M Viljoen Sr
Title
Cited by
Cited by
Year
SARS-CoV-2 Variants, Vaccines, and Host Immunity
P Mistry, F Barmania, J Mellet, K Peta, A Strydom, IM Viljoen, ...
Frontiers in Immunology 12 (809244), 2022
2662022
Contact tracing during the COVID-19 pandemic: Protection of personal information in South Africa
C De Villebois Castelyn, M Botes, IM Viljoen, A Pope, MS Pepper
South African Journal of Bioethics and Law 13 (1), 20-25, 2020
142020
Open access and its potential impact on public health–A South African perspective
A Strydom, J Mellet, J Van Rensburg, IM Viljoen, A Athanasiadis, ...
Frontiers Media, 2022
112022
Resource allocation during COVID-19: A focus on vulnerable populations
CV Castelyn, IM Viljoen, A Dhai, MS Pepper
South African Journal of Bioethics and Law 13 (2), 83-86, 2020
102020
Perspectives on establishing a public cord blood inventory in South Africa
IM Viljoen, CL Hendricks, J Mellet, MS Pepper
Cytotherapy 23 (6), 548-557, 2021
62021
Regenerative medicines: A new regulatory paradigm for South Africa
IM Viljoen, CL Hendricks, HL Malherbe, MS Pepper
Biochimie 196, 123-130, 2022
22022
When cells become medicines: A South African perspective
IM Viljoen, MS Pepper
South African Medical Journal 111 (11), 1055 - 1059, 2021
22021
The system can't perform the operation now. Try again later.
Articles 1–7